Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

Alhussien AH, Alhedaithy RA, Alsaleh SA.

Eur Arch Otorhinolaryngol. 2017 Nov 21. doi: 10.1007/s00405-017-4785-3. [Epub ahead of print] Review.

PMID:
29164323
2.

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

Onland W, Offringa M, van Kaam A.

Cochrane Database Syst Rev. 2017 Aug 24;8:CD002311. doi: 10.1002/14651858.CD002311.pub4. Review.

PMID:
28836266
3.

Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.

Tomizawa Y, Melek J, Komaki Y, Kavitt RT, Sakuraba A.

J Clin Gastroenterol. 2017 Aug 4. doi: 10.1097/MCG.0000000000000878. [Epub ahead of print]

PMID:
28787360
4.
5.

Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.

Yeo SH, Aggarwal B, Shantakumar S, Mulgirigama A, Daley-Yates P.

Expert Rev Respir Med. 2017 Oct;11(10):763-778. doi: 10.1080/17476348.2017.1361824. Epub 2017 Aug 4.

PMID:
28752776
6.

Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis.

Yang M, Chen H, Zhang Y, Du Y, Xu Y, Jiang P, Xu Z.

Inhal Toxicol. 2017 Apr;29(5):219-226. doi: 10.1080/08958378.2017.1346006. Epub 2017 Jul 17.

PMID:
28714745
7.

Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression.

Cotton CC, Eluri S, Wolf WA, Dellon ES.

Dig Dis Sci. 2017 Sep;62(9):2408-2420. doi: 10.1007/s10620-017-4642-7. Epub 2017 Jun 12. Review.

PMID:
28608048
8.

[Risk of pneumonia during long term regular treatment of stable COPD with inhaled glucocorticoids: a systematic review.]

Arpinelli F, Caramori G, Magnoni MS.

Recenti Prog Med. 2017 Apr;108(4):175-182. doi: 10.1701/2681.27453. Italian.

PMID:
28492586
9.

Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children with Eosinophilic Esophagitis.

Fable JM, Fernandez M, Goodine S, Lerer T, Sayej WN.

J Pediatr Gastroenterol Nutr. 2017 May 9. doi: 10.1097/MPG.0000000000001626. [Epub ahead of print]

PMID:
28489670
10.

Emollients and moisturizers for eczema: abridged Cochrane systematic review including GRADE assessments.

van Zuuren EJ, Fedorowicz Z, Arents BWM.

Br J Dermatol. 2017 Nov;177(5):1256-1271. doi: 10.1111/bjd.15602. Epub 2017 Oct 1. Review.

PMID:
28432721
11.

Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis.

El Baou C, Di Santostefano RL, Alfonso-Cristancho R, Suarez EA, Stempel D, Everard ML, Barnes N.

BMC Pulm Med. 2017 Feb 7;17(1):31. doi: 10.1186/s12890-016-0348-4. Review. Erratum in: BMC Pulm Med. 2017 Dec 5;17 (1):172.

12.

Intranasal fluticasone associated with delayed tympanostomy tube placement in children with eustachian tube dysfunction.

Crowson MG, Ryan MA, Ramprasad VH, Choi KJ, Raynor E.

Int J Pediatr Otorhinolaryngol. 2017 Mar;94:121-126. doi: 10.1016/j.ijporl.2017.01.023. Epub 2017 Jan 21.

PMID:
28167002
13.

Fluticasone Furoate/Vilanterol (Breo Ellipta) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.

14.

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.

Svedsater H, Stynes G, Wex J, Frith L, Leather D, Castelnuovo E, Detry M, Berry S.

Asthma Res Pract. 2016 Feb 8;2:4. doi: 10.1186/s40733-015-0016-0. eCollection 2016.

15.

Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis.

Cotton CC, Erim D, Eluri S, Palmer SH, Green DJ, Wolf WA, Runge TM, Wheeler S, Shaheen NJ, Dellon ES.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):841-849.e1. doi: 10.1016/j.cgh.2016.11.032. Epub 2016 Dec 7.

PMID:
27940272
16.

A systematic review with meta-analysis of fluticasone furoate/vilanterol combination for the treatment of stable COPD.

Rodrigo GJ, Neffen H.

Pulm Pharmacol Ther. 2017 Feb;42:1-6. doi: 10.1016/j.pupt.2016.11.003. Epub 2016 Nov 15. Review.

PMID:
27864038
17.

Oesophageal lichen planus: the efficacy of topical steroid-based therapies.

Podboy A, Sunjaya D, Smyrk TC, Murray JA, Binder M, Katzka DA, Alexander JA, Halland M.

Aliment Pharmacol Ther. 2017 Jan;45(2):310-318. doi: 10.1111/apt.13856. Epub 2016 Nov 17.

PMID:
27859412
18.

Inhaled Fluticasone-Salmeterol Better Than Fluticasone Alone for Moderate to Severe Asthma.

Ebell MH.

Am Fam Physician. 2016 Sep 1;94(5):387. No abstract available.

19.

Vilanterol and fluticasone furoate for asthma.

Dwan K, Milan SJ, Bax L, Walters N, Powell C.

Cochrane Database Syst Rev. 2016 Sep 1;9:CD010758. [Epub ahead of print] Review.

PMID:
27582089
20.

Inhaled corticosteroids for cystic fibrosis.

Balfour-Lynn IM, Welch K.

Cochrane Database Syst Rev. 2016 Aug 23;(8):CD001915. doi: 10.1002/14651858.CD001915.pub5. Review.

PMID:
27552284

Supplemental Content

Loading ...
Support Center